Liver surgery and weight loss surgery for liver cancer with metabolic syndrome
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial tests if combining liver resection (surgery to remove liver cancer) with sleeve gastrectomy (weight loss surgery) is safe and effective for people whose liver cancer is caused by metabolic syndrome. It may help those who also qualify for bariatric surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have liver cancer (hepatocellular carcinoma) caused only by metabolic syndrome.
- Your liver function must be good (Child-Pugh score A).
- You must be a candidate for laparoscopic or robotic liver surgery.
- Your body mass index (BMI) must be 40 or higher, or 35-40 with other health issues, or 30-35 with type 2 diabetes or poorly controlled high blood pressure.
- You must be willing to have both liver and weight loss surgeries.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares bariatric (weight-loss) surgery with medical (non-surgery) treatment in people with metabolic syndrome, a cluster of risk factors that can affect heart and blood sugar. It aims to see which approach improves these health risks and overall metabolism.
This trial studies whether vertical sleeve gastrectomy (a type of weight-loss surgery) plus lifestyle coaching works better than another planned approach to improve non-alcoholic steatohepatitis (NASH), a serious form of fatty liver disease. It may help people reduce liver fat and inflammation, but you must be willing to follow study visits and possible random assignment.
This study looks at how fat build-up in the liver relates to metabolism in people who are scheduled for weight-loss (bariatric) surgery. By doing special blood tests and MRI scans, researchers hope to better understand liver health and improve care.
This study tests whether bariatric surgery (either sleeve gastrectomy or Roux-en-Y gastric bypass) improves severe nonalcoholic steatohepatitis (NASH) with advanced liver scarring in people who are obese. You may also need liver biopsies to confirm your liver disease before and after treatment.
This trial tests if doing a TIPS procedure (to lower blood pressure in the liver) before weight-loss surgery (sleeve gastrectomy) helps people with advanced liver disease. It's for those who have cirrhosis and very high blood pressure in the liver, and who qualify for sleeve gastrectomy.
This study tests if a procedure called endoscopic sleeve gastroplasty helps people with obesity and a liver condition called MASH lose weight and improve their liver health. It might be an option if you have both obesity and MASH and haven't had weight-loss surgery before.
Hear when a new Metabolic Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.